77 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
their duties. Reimbursement or payment of such expenses will be made in accordance with the Company’s policies and procedures provided in the Employee
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including
8-K
EX-10.1
28g9t lb3genxb
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
732 a2mqxbgt5pftdivt
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
bm7dn bnhcdfglpna
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
l6t8bzzyfkn
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
r9roq 92s
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
92pszpif
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
7ouo78zy
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
pe616 94k1l054u
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
9lblh92x3i
7 Apr 22
Prospectus supplement
4:46pm